Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87,054,674
-
Total 13F shares
-
32,044,753
-
Share change
-
-436,388
-
Total reported value
-
$531,121,734
-
Price per share
-
$16.59
-
Number of holders
-
100
-
Value change
-
-$3,584,064
-
Number of buys
-
46
-
Number of sells
-
37
Institutional Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q1 2019
As of 31 Mar 2019,
Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,044,753 shares.
The largest 10 holders included
EcoR1 Capital, LLC, GREAT POINT PARTNERS LLC, BVF INC/IL, BlackRock Inc., EAGLE ASSET MANAGEMENT INC, FMR LLC, VICTORY CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, ARCH VENTURE CORP, and CARILLON TOWER ADVISERS, INC..
This page lists
100
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.